Breaking News Instant updates and real-time market news.

ETNB

89bio

$28.38

0.86 (3.13%)

07:33
12/09/19
12/09
07:33
12/09/19
07:33

89bio initiated with an Outperform at Oppenheimer

Oppenheimer analyst Jay Olson initiated coverage of 89bio with an Outperform rating and $60 price target. In a research note to investors, Olson says he believes BIO89-100 has potential to become a foundational nonalcoholic steatohepatitis and severe hypertriglyceridemia therapy as best-in-class among fibroblast growth factor 21 analogs. He estimates peak sales in NASH of $2.7B and in SHTG of $2.1B in 2037.

ETNB 89bio
$28.38

0.86 (3.13%)

12/09/19
BOFA
12/09/19
INITIATION
Target $33
BOFA
Neutral
89bio initiated with a Neutral at BofA/Merrill
BofA/Merrill initiated coverage of 89bio with a Neutral rating and $33 price target.
12/09/19
BOFA
12/09/19
INITIATION
Target $33
BOFA
Neutral
89bio initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad initiated coverage of 89bio with a Neutral rating and $33 price target. The analyst believes the company's BIO89-100 can address an undermet need in a "crowded" nonalcoholic steatohepatitis space. Ahmad currently estimates risk-adjusted peak sales of $688M in 2033 for NASH and an under 20% likelihood of success.
12/09/19
RBCM
12/09/19
INITIATION
Target $36
RBCM
Outperform
89bio initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams initiated coverage of 89bio with an Outperform rating and $36 price target. The analyst notes that the company's lead drug BIO89-100 offers a "good long-term potential" to address the nonalcoholic steatohepatitis, or NASH, pathology as well as its underlying metabolic causes while generating total world-wide sales of about $1.4B. Abrahams adds that while the recent 79% run-up in the stock price has taken 89bio valuation to more "appropriate" levels to reflect the drug's promise relative to development hurdles, he still sees multiple opportunities for additional upside value inflections coming in 2020 with "evolving FGF21 agents data and increasing NASH market clarity".
12/09/19
LEER
12/09/19
INITIATION
Target $55
LEER
Outperform
89bio initiated with an Outperform at SVB Leerink
SVB Leerink analyst Pasha Sarraf initiated coverage of 89bio with an Outperform rating and $55 price target.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,864.40

-13.55 (-0.72%)

, V

Visa

$204.71

3.765 (1.87%)

06:19
01/21/20
01/21
06:19
01/21/20
06:19
Periodicals
Amazon working with Visa to let consumers pay with their palms, WSJ reports »

Amazon (AMZN) is working…

AMZN

Amazon.com

$1,864.40

-13.55 (-0.72%)

V

Visa

$204.71

3.765 (1.87%)

MA

MasterCard

$323.60

3.36 (1.05%)

JPM

JPMorgan

$138.15

0.89 (0.65%)

WFC

Wells Fargo

$49.18

-0.07 (-0.14%)

SYF

Synchrony

$35.77

0.305 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 10

    Feb

  • 11

    Feb

  • 25

    Feb

  • 26

    Feb

  • 14

    Apr

  • 14

    Apr

LB

L Brands

$20.16

-0.14 (-0.69%)

06:18
01/21/20
01/21
06:18
01/21/20
06:18
Upgrade
KeyBanc upgrades L Brands to Overweight on possible value creating transaction »

KeyBanc analyst Edward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

KSU

Kansas City Southern

$166.57

4.77 (2.95%)

06:18
01/21/20
01/21
06:18
01/21/20
06:18
Recommendations
Kansas City Southern analyst commentary  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGLD

Internet Gold

$0.00

(0.00%)

06:18
01/21/20
01/21
06:18
01/21/20
06:18
Hot Stocks
Internet Gold announces creditors approval of settlement agreement »

Internet Gold - Golden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YNDX

Yandex

$45.41

1.3 (2.95%)

, GOOGL

Alphabet Class A

$1,479.12

29.29 (2.02%)

06:16
01/21/20
01/21
06:16
01/21/20
06:16
Periodicals
Yandex lags behind others in cutting down child abuse images, Fortune reports »

Yandex (YNDX),…

YNDX

Yandex

$45.41

1.3 (2.95%)

GOOGL

Alphabet Class A

$1,479.12

29.29 (2.02%)

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

MSFT

Microsoft

$167.06

0.82 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

  • 14

    Feb

  • 25

    Feb

TEL

TE Connectivity

$100.19

0.71 (0.71%)

, APH

Amphenol

$109.45

-0.29 (-0.26%)

06:14
01/21/20
01/21
06:14
01/21/20
06:14
Upgrade
TE Connectivity, Amphenol, Sensata rating change  »

JPMorgan upgrades TE…

TEL

TE Connectivity

$100.19

0.71 (0.71%)

APH

Amphenol

$109.45

-0.29 (-0.26%)

ST

Sensata

$52.65

-0.15 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 03

    Feb

  • 11

    Feb

IMV

IMV Inc.

$3.96

-0.06 (-1.49%)

06:14
01/21/20
01/21
06:14
01/21/20
06:14
Upgrade
IMV Inc. rating change  »

IMV Inc. upgraded on DPX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMO

General Moly

$0.23

-0.0016 (-0.68%)

06:12
01/21/20
01/21
06:12
01/21/20
06:12
Hot Stocks
General Moly says CPM projects $12.58 per lb average moly real price for 2020 »

During the first 10…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$24.88

0.06 (0.24%)

06:11
01/21/20
01/21
06:11
01/21/20
06:11
Upgrade
Jeld-Wen rating change  »

Jeld-Wen upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

EVNVY

EVN AG

$0.00

(0.00%)

06:11
01/21/20
01/21
06:11
01/21/20
06:11
Downgrade
EVN AG rating change  »

EVN AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMO

General Moly

$0.23

-0.0016 (-0.68%)

06:10
01/21/20
01/21
06:10
01/21/20
06:10
Hot Stocks
General Moly entering 'next phase' of evaluating strategic alternatives »

General Moly announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIQT

LiqTech

$6.50

0.05 (0.78%)

06:09
01/21/20
01/21
06:09
01/21/20
06:09
Earnings
LiqTech sees Q1 revenue approximately $12M, consensus $11.48M »

CEO Sune Mathiesen said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MONDY

Mondi

$0.00

(0.00%)

06:08
01/21/20
01/21
06:08
01/21/20
06:08
Downgrade
Mondi rating change  »

Mondi downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIQT

LiqTech

$6.50

0.05 (0.78%)

06:08
01/21/20
01/21
06:08
01/21/20
06:08
Earnings
Breaking Earnings news story on LiqTech »

LiqTech reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$3.27

-0.16 (-4.66%)

06:07
01/21/20
01/21
06:07
01/21/20
06:07
Upgrade
Accuray rating change  »

Accuray upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

FQVTF

Fevertree Drinks

$0.00

(0.00%)

06:07
01/21/20
01/21
06:07
01/21/20
06:07
Downgrade
Fevertree Drinks rating change  »

Fevertree Drinks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$12.76

0.115 (0.91%)

06:06
01/21/20
01/21
06:06
01/21/20
06:06
Earnings
F.N.B. reports Q4 ex-items EPS 30c, consensus 29c »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

DCP

DCP Midstream

$24.50

-0.45 (-1.80%)

, APY

Apergy

$30.97

-0.2 (-0.64%)

06:06
01/21/20
01/21
06:06
01/21/20
06:06
Hot Stocks
DCP Midstream and Windrock to jointly develop AI solutions »

DCP Midstream (DCP) and…

DCP

DCP Midstream

$24.50

-0.45 (-1.80%)

APY

Apergy

$30.97

-0.2 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 23

    Mar

PEBO

Peoples Bancorp

$34.67

-0.11 (-0.32%)

06:05
01/21/20
01/21
06:05
01/21/20
06:05
Earnings
Peoples Bancorp reports Q4 EPS 72c, consensus 68c »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

LBTYA

Liberty Global

$21.15

-0.315 (-1.47%)

, VOD

Vodafone

$20.08

-0.22 (-1.08%)

06:04
01/21/20
01/21
06:04
01/21/20
06:04
Downgrade
Liberty Global, Vodafone rating change  »

Jefferies downgrades…

LBTYA

Liberty Global

$21.15

-0.315 (-1.47%)

VOD

Vodafone

$20.08

-0.22 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

AXNX

Axonics

$31.51

-0.015 (-0.05%)

06:03
01/21/20
01/21
06:03
01/21/20
06:03
Hot Stocks
Axonics announces FDA approval of second-generation Programmer for r-SNM System »

Axonics Modulation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

UNTY

Unity Bancorp

$21.32

-0.26 (-1.20%)

06:03
01/21/20
01/21
06:03
01/21/20
06:03
Earnings
Breaking Earnings news story on Unity Bancorp »

Unity Bancorp reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARES

Ares Management

$37.29

0.47 (1.28%)

06:01
01/21/20
01/21
06:01
01/21/20
06:01
Hot Stocks
Ares Management to acquire majority interest in SSG Capital Holdings »

Ares Management announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 26

    Feb

MSG

Madison Square Garden

$305.06

0.225 (0.07%)

05:56
01/21/20
01/21
05:56
01/21/20
05:56
Recommendations
Madison Square Garden analyst commentary  »

Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$34.70

-0.03 (-0.09%)

05:56
01/21/20
01/21
05:56
01/21/20
05:56
Hot Stocks
Bank of America achieves carbon neutrality »

Bank of America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 26

    Feb

  • 15

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.